Research consortium offers new hope for Parkinson's disease

Until recently, research progress in the field of Parkinson's disease has been slow compared with other therapeutic areas. However, a new consortium of pharmaceutical companies, academic researchers and charities – the Critical Path for Parkinson's Consortium – is helping to accelerate the development of new treatments to slow disease progression.
Source: Prescriber - Category: Primary Care Authors: Tags: Research Source Type: research